UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000014838
Receipt No. R000017111
Official scientific title of the study Study on the efficacy of 5ASA oral formula and suppository against relapse of proctitis
Date of disclosure of the study information 2014/08/12
Last modified on 2018/08/15 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study on the efficacy of 5ASA oral formula and suppository against relapse of proctitis
Title of the study (Brief title) Oral vs. suppository 5ASA against relapse of proctitis
Region
Japan

Condition
Condition proctitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the efficacy of remission induction in relapsed proctitis between 5ASA suppository and 5ASA oral formula
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes improvement in endoscopic Mayo score 4 weeks after the intervention
Key secondary outcomes proportion of patients without relapse of rectal bleeding after 1 year of maintenance therapy

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 asacol 3.6g t.i.d 4 weeks
Interventions/Control_2 pentasa suppository 1g/day 4 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria Having been diagnosed as proctitis by colonoscopy more than 6 months before
Having been on maintenance therapy with oral 5ASA (2.4g/day or less), oral sulfasalazine (3g/day or less), sulfasalazine suppository, or 5ASA suppository(1 in two days or less), or no maintenance therapy, which has not been changed for at least 2 months prior to the study entry
Bleeding Mayo score > 0
Given written informed consent
Eendoscopic Mayo score > 0
No active inflammation in area more than 15cm from the anal verge on colonoscopy
Key exclusion criteria Pregnant or nursing female
Patients who received steroids, immunosuppressants, immunomodulators, anti-TNF alpha, or leucocytapheresis within 3 months before the study entry
Those with severe liver or renal dysfunction
Those with a history of hypersensitivity against mesalazine
Those who were regarded inadequate for this study
Target sample size 140

Research contact person
Name of lead principal investigator Nobuyuki Matsuhashi
Organization NTT Medical Center Tokyo
Division name Dept of Gastroenterology
Address 5-9-22 Higashigotanda Shinagawa-ku, Tokyo
TEL 03-3448-6245
Email nmatuha-tky@umin.ac.jp

Public contact
Name of contact person Nobuyuki Matsuhashi
Organization NTT Medical Center Tokyo
Division name Dept of Gastroenterology
Address 5-9-22 Higashigotanda Shinagawa-ku, Tokyo
TEL 03-3448-6245
Homepage URL
Email nmatuha-tky@umin.ac.jp

Sponsor
Institute NTT Medical Center Tokyo
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 08 Month 12 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 08 Month 12 Day
Anticipated trial start date
2014 Year 08 Month 12 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 08 Month 12 Day
Last modified on
2018 Year 08 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017111